SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?


To: Joe Dancy who wrote (91)7/7/1998 10:22:00 AM
From: Mason Barge  Read Replies (2) | Respond to of 422
 
Better get in now, Joe, the momentum's on slow burn. Bid/ask right now is at 10 1/2 by 10 5/8, and I watched as the MM (it used to be Olde, not sure now, maybe Stern Agee has joined them) sold 20,000 at ask without budging the spread.

There can't be much left for sale (and this is total speculation on my part). I would think any coverage, even by a little guy, or any leaks of takeover inquiries by a major pharmaceutical (I've heard specualtion on J&J), would be enough to crank this one up fast. The float is very small, and biotechs that are making a steady base profit are a rarity.



To: Joe Dancy who wrote (91)7/7/1998 10:29:00 AM
From: Thomas Kirwin  Respond to of 422
 
Earnings Release Date

Immucor's Investor Relations has informed me that their 4th quarter and annual earnings as of May 31, 1998 should be released within the next couple of weeks. Perhaps we will see some news regarding sales of ABS2000, DIAS PLUS or Rosys Plato.

Regards,

Tom